Lilly to pay up to $370M for OmniAb collab; Slate, Fulcrum forge reverse merger

🤝 OmniAb’s Lilly pact: The California drug discovery shop has an ion channel collaboration and licensing agreement in place with the GLP-1 giant. Eli Lilly will pay up to $370 million ...